Transplantation of iPSC-HLCs significantly attenuated liver fibrosis induced by CCL4 (80); hence, iPSC-HLCs may be used as a novel therapeutic strategy for the treatment of liver fibrosis. Here, CCL4 is linked to Hepatic fibrosis.